Statins for people with kidney disease

Editorial

Catherine M Clase. BMJ. 2008.

. 2008 Mar 22;336(7645):624-5.

doi: 10.1136/bmj.39483.665139.80. Epub 2008 Feb 25.

Abstract

Criteria for treatment should be the same as for people with normal kidney function

Competing interests: CMC has organised educational rounds sponsored by drug companies that make statins.

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.
Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC. Strippoli GF, et al. BMJ. 2008 Mar 22;336(7645):645-51. doi: 10.1136/bmj.39472.580984.AE. Epub 2008 Feb 25. BMJ. 2008. PMID: 18299289 Free PMC article. Review.

1. Strippoli GFM, Navaneethan SD, Johnson D, Perkovic V, Pellegrini F, Nicolucci A, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 2008. doi: - DOI - PMC - PubMed
1. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17:2034-47. - PubMed
1. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II study. Arch Intern Med 2007;167:2490-6. - PubMed
1. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M, et al. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 2006;332:1426. - PMC - PubMed
1. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996;11:1277-85. - PubMed